[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit ::
Main Menu
Home::
Journal Information::
About the Journal & Policies
Editorial Board
Articles Archive::
Current Issue
All Issues
Guide for Authors::
Author instructions
Guide for publishing in journal
Submission Form
Author's consent form
For Reviewers::
Reviewers Section
Ethical Statements::
Registration::
Registration Form
Site Facilities::
Site map
Inform to friends
Contact us::
Contact Information
::
Indexed by
     
..
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Copyright Policies

 

AWT IMAGE

 
..
Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

..
:: Articles In Press ::
Back to the articles list Back to browse issues page
The Effect of Interval Training on Cdk5/P25/Tau Gene Expression in the Hippocampus of Streptozotocin-Induced Alzheimer's Disease Rat
Zahra Barati , Ali Yaghoubi * , Farzaneh Shakeri , Najmeh Rezaeian , Mohsen Tavakoli
Department of Sport Sciences, Bojnourd Branch, Islamic Azad University, Bojnourd, Iran , al.yaghoubi@iau.ir
Abstract:   (13 Views)
Introduction: Cyclin-dependent kinase 5 (Cdk5) and p25 are involved in the abnormal hyperphosphorylation of tau protein. The aim of this study was to investigate the effects of interval training on the expression of Cdk5, p25, and tau proteins in the hippocampus of streptozotocin (STZ)-induced Alzheimer's disease rats. Materials and Methods: For this purpose, 30 male Wistar rats (8 weeks old; 200–250 g) were used. The animals were randomly assigned to three equal groups (n = 10 per group): healthy control, Alzheimer's disease control, and Alzheimer's disease training. Alzheimer's disease was induced by intracerebroventricular injection of STZ at a dose of 3 mg/kg. The training group underwent an interval training protocol consisting of 6–12 high-intensity bouts (1 min at 85–90% VO₂max) interspersed with 5 min of low-intensity running at a speed of 10 m/min on a treadmill. Seventy-two hours after the final training session, hippocampal tissue was removed, and the protein expression levels of Cdk5, p25, and tau were determined by Western blot analysis .Results: The expression levels of Cdk5, p25 and tau genes in the hippocampus of the Alzheimer's control group were significantly higher than in the healthy control group. The expression levels of Cdk5, p25 and tau genes in the Alzheimer's training group were significantly lower than in the Alzheimer's control group .Conclusion: Our findings suggest that interval training may help alleviate neurodegeneration associated with Alzheimer's disease through modulation of the Cdk5/p25 pathway and subsequent reduction in tau protein expression. Further research is needed to evaluate its potential as a complementary therapeutic intervention for Alzheimer's disease.

 
Keywords: tau Proteins, Cyclin-Dependent Kinase 5, Exercise, Neurodegenerative Diseases
     
Type of Study: Research --- Open Access, CC-BY-NC | Subject: Neurophysiology
References
1. Abdulkhaliq AA, Kim B, Almoghrabi YM, Khan J, Ajoolabady A, Ren J, et al. Amyloid-β and Tau in Alzheimer's disease: pathogenesis, mechanisms, and interplay. 2026; 17(1) :21. [DOI:10.1038/s41419-025-08186-8]
2. Yaghoubi A. Changes in Aβ42, Neprilysin, and γ-Secretase in the Hippocampus of Male Rats Alzheimer's model: The Effects of Aerobic Training and Omega-3 Intake %J Journal of Kerman University of Medical Sciences. 2023; 30(3): 136-45. [DOI:10.34172/jkmu.2023.23]
3. Iqbal K, Liu F, Gong C-XJNrn. Tau and neurodegenerative disease: the story so far. 2016; 12(1): 15-27. [DOI:10.1038/nrneurol.2015.225]
4. Zhang X, Wang J, Zhang Z, Ye KJTN. Tau in neurodegenerative diseases: molecular mechanisms, biomarkers, and therapeutic strategies. 2024; 13(1): 40. [DOI:10.1186/s40035-024-00429-6]
5. Serrano-Pozo A, Frosch MP, Masliah E, Hyman BTJCSHpim. Neuropathological alterations in Alzheimer disease. 2011; 1(1): a006189. [DOI:10.1101/cshperspect.a006189]
6. Arnsten AF, Del Tredici K, Barthélemy NR, Gabitto M, van Dyck CH, Lein E, et al. An integrated view of the relationships between amyloid, tau, and inflammatory pathophysiology in Alzheimer's disease. 2025; 21(8): e70404. [DOI:10.1002/alz.70404]
7. Jahan I, Adachi R, Egawa R, Nomura H, Kuba HJJoN. CDK5/p35-dependent microtubule reorganization contributes to homeostatic shortening of the axon initial segment. 2023; 43(3): 359-72. [DOI:10.1523/JNEUROSCI.0917-22.2022]
8. Jiang T, Chang RC-C, Rosenmann H, Yu J-TJBRI. Advances in Alzheimer's disease: From bench to bedside. 2015; 2015: 202676. [DOI:10.1155/2015/202676]
9. Piedrahita D, Hernández I, López-Tobón A, Fedorov D, Obara B, Manjunath B, et al. Silencing of CDK5 reduces neurofibrillary tangles in transgenic alzheimer's mice. 2010; 30(42): 13966-76. [DOI:10.1523/JNEUROSCI.3637-10.2010]
10. Kumari S, Singh AK, Kumar M, Pradhan R, Rao AR, Yadav Y, et al. Targeting a Tau Kinase Cdk5, Cyclin-Dependent Kinase: A Blood-Based Diagnostic Marker and Therapeutic Earmark for Alzheimer's Disease. 2025; 15(10): 1365. [DOI:10.3390/biom15101365]
11. Giese KPJFimn. Generation of the Cdk5 activator p25 is a memory mechanism that is affected in early Alzheimer's disease. 2014; 7: 36. [DOI:10.3389/fnmol.2014.00036]
12. Pahlavani HAJFiAN. Exercise therapy to prevent and treat Alzheimer's disease. 2023; 15: 1243869. [DOI:10.3389/fnagi.2023.1243869]
13. Chapman SB, Aslan S, Spence JS, DeFina LF, Keebler MW, Didehbani N, et al. Shorter term aerobic exercise improves brain, cognition, and cardiovascular fitness in aging. 2013; 5: 75. [DOI:10.3389/fnagi.2013.00075]
14. Li W, Wang W-H, Song Y, Li X-J, Li Y, Wang X, et al. Mechanistic advances in exercise‑mediated regulation of autophagy dysfunction in Alzheimer's disease. 2026; 57(4): 1-16. [DOI:10.3892/ijmm.2026.5755]
15. Kang J, Liu M, Yang Q, Dang X, Li Q, Wang T, et al. Exercise training exerts beneficial effects on Alzheimer's disease through multiple signaling pathways. 2025; 17: 1558078. [DOI:10.3389/fnagi.2025.1558078]
16. Saghebjoo M, ia Fallah-Mohammadi Z, Hedayati M, Moghaddam AHJK. Effects of eight weeks aerobic training on levels of amyloid β42, neprilysin and γ-secretase in the hippocampus of male rat Alzheimer's model by homocysteine injection. 2016; 17(4): 996-1005.
17. Mattson MPJCm. Energy intake and exercise as determinants of brain health and vulnerability to injury and disease. 2012; 16(6): 706-22. [DOI:10.1016/j.cmet.2012.08.012]
18. Sampaio A, Marques EA, Mota J, Carvalho JJD. Effects of a multicomponent exercise program in institutionalized elders with Alzheimer's disease. 2019; 18(2): 417-31. [DOI:10.1177/1471301216674558]
19. Moreira-Silva D, Vizin RC, Martins TM, Ferreira TL, Almeida MC, Carrettiero DCJB-p. Intracerebral injection of streptozotocin to model Alzheimer disease in rats. 2019; 9(20): e3397-e. [DOI:10.21769/BioProtoc.3397]
20. Yaghoubi AJJoKUoMS. Changes in Aβ42, Neprilysin, and γ-Secretase in the Hippocampus of Male Rats Alzheimer's model: The Effects of Aerobic Training and Omega-3 Intake. 2023; 30(3): 136-45. [DOI:10.34172/jkmu.2023.23]
21. Azarniveh MS, Vahdatpoor H, Khademosharie M, Balaghi Inaloo F, Taheri AJAoASS. The effect of eight weeks of High-Intensity interval training on plasma LRP1, AB1-42, and insulin resistance in obese elderly diabetic rats. 2024; 12(4).
22. Mohammadzadeh E, Alipour F, Khallaghi B. Evaluation of Spatial Memory Impairment after Intracerebroventricular Streptozocin Injection in Adult Rats. The Neuroscience Journal of Shefaye Khatam. 2014; 2(1): 40-5. [DOI:10.18869/acadpub.shefa.2.1.40]
23. Pasand Mozhdeh H, Zeynali HA, Iraj Kashani Radgerdi, Sahab Negah s, Hassanzadeh G. The Effect of Intracerebroventricular Administration of Streptozocin on Cell Proliferation in Subventricular Zone Stem Cells in a Rat Model of Alzheimer's Disease. The Neuroscience Journal of Shefaye Khatam. 2015; 3(4): 80-5. [DOI:10.18869/acadpub.shefa.3.4.80]
24. Kazemi A, Rahmati M, MONTAZER S. The effect of decreased activity in the form of spinal cord ligation on cdk5 expression in sciatic nerve and behavioral test of wistar male rats with neuropathic pain. 2016.
25. Wang Y, Sheng H, Zhao J, Guo L, Liu J, Xu J, et al. Changes in the prefrontal cortex after the hippocampus was injected with Aβ25-35 via the P35/P25-CDK5-Tau hyperphosphorylation signaling pathway. 2021; 741: 135453. [DOI:10.1016/j.neulet.2020.135453]
26. Huang Y, Huang W, Huang Y, Song P, Zhang M, Zhang H-T, et al. Cdk5 inhibitory peptide prevents loss of neurons and alleviates behavioral changes in p25 transgenic mice. 2020; 74(4): 1231-42. [DOI:10.3233/JAD-191098]
27. Bayod S, Del Valle J, Canudas AM, Lalanza JF, Sanchez-Roigé S, Camins A, et al. Long-term treadmill exercise induces neuroprotective molecular changes in rat brain. Journal of Applied Physiology. 2011; 111(5): 1380-90. [DOI:10.1152/japplphysiol.00425.2011]
28. Um H-S, Kang E-B, Koo J-H, Kim H-T, Kim E-J, Yang C-H, et al. Treadmill exercise represses neuronal cell death in an aged transgenic mouse model of Alzheimer's disease. Neuroscience research. 2011; 69(2): 161-73. [DOI:10.1016/j.neures.2010.10.004]
29. Ohia-Nwoko O, Montazari S, Lau Y-S, Eriksen JL. Long-term treadmill exercise attenuates tau pathology in P301S tau transgenic mice. Molecular neurodegeneration. 2014; 9(1): 1-17. [DOI:10.1186/1750-1326-9-54]
30. Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C. Potential for primary prevention of Alzheimer's disease: an analysis of population-based data. The Lancet Neurology. 2014; 13(8): 788-94. [DOI:10.1016/S1474-4422(14)70136-X]
31. Engmann O, Hortobágyi, T., Thompson, A. J., Guadagno, J., Troakes, C., Soriano, S., AlSarraj, S., Kim, Y., & Giese, K. P. . Cyclindependent kinase 5 activator p25 is generated during memory formation and is reduced at an early stage in Alzheimer's disease. Biological Psychiatry. 2011; 70(2): 10. [DOI:10.1016/j.biopsych.2011.04.011]
32. Liu Y, Chu, J.M.T., Yan, T., et al. . Short-term resistance exercise inhibits neuroinflammation and attenuates neuropathological changes in 3xTg Alzheimer's disease mice. Journal of Neuroinflammation. 2017; 17(1): 1-15. [DOI:10.1186/s12974-019-1653-7]
33. García-Mesa Y, López-Ramos, J.C., Giménez-Llort, L., et al. . Physical exercise protects against Alzheimer's disease in 3xTg-AD mice. Journal of Alzheimer's Disease. 2016; 50(4): 785-90.
34. Zhang J, Li, H., & Yabut, O. . Cdk5 inhibitors as potential therapeutic agents for the treatment of Alzheimer's disease. Journal of Medicinal Chemistry. 2020; 63(15): 8178-94.
35. Cho SY, So, W.Y., Roh, H.T. . Resistance training improves cognitive function and decreases tau phosphorylation in APP/PS1 transgenic mice. Experimental Gerontology. 2018; 110(2): 284-91.

XML   Persian Abstract   Print

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Back to the articles list Back to browse issues page
مجله علوم اعصاب شفای خاتم The Neuroscience Journal of Shefaye Khatam
Persian site map - English site map - Created in 0.05 seconds with 47 queries by YEKTAWEB 4743